Catalyst Pharmaceuticals Inc. CPRX
$31.37
▼ -0.03% 24H
About
Catalyst Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, particularly in neuromuscular, neurological, and metabolic areas. Its primary products include FIRDAPSE (a…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees182
TickerCPRX
Statistics
Market Cap$3.83B
Revenue (TTM)$589.0M
Net Income$214.3M
Net Margin36.4%
EPS$1.68
P/E18.13
P/S6.43
P/B3.78
EV/EBITDA10.08
ROE24.5%
Dividend Yield—
Price$31.37
Data: Twelve Data · Revenue = mcap / P/S